Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study is a Stage III randomized trial to encourage patients in advance of a health care appointment to designate a healthcare proxy. Patients will be randomly assigned to receive a mailer containing information about designating a healthcare proxy, or to not receive any mailer. For patients assigned to receive a mailer, the mailer will differ by the presence or absence of a patient pre-commitment prompt, and contain a personalized provider request or a generic health system request. The work will evaluate the randomized trial and identify factors that predict intervention effectiveness.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10,000 participants in 5 patient groups
Loading...
Central trial contact
Tara K Knight, PhD; Mireille Jacobson, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal